Gabapentin Capsule
Product Images NDC 71335-1199

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71335-1199). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin-equation (Gabapentin Equation)

A formula for calculating creatinine clearance (CLCr), expressed as a fraction involving age, weight, serum creatinine levels, and a gender adjustment factor for females. The formula shows division and multiplication elements with variables in parentheses.*

FDA Label Image

Gabapentin-fig1 (Gabapentin Fig1)

A line graph depicting mean pain scores over an 8-week period comparing placebo and Gabapentin 3600 mg/day. The x-axis shows weeks from baseline to 8, segmented into a 4-week dose titration period and a 4-week fixed dose period. The y-axis displays mean pain scores ranging from 0 to 10. Gabapentin shows a decreasing pain score trend, while placebo remains relatively stable.*

FDA Label Image

Gabapentin-fig2 (Gabapentin Fig2)

Line graph depicting the mean pain score over a 7-week period, including a 3-week dose titration period and a 4-week fixed dose period. The graph compares placebo with gabapentin at doses of 1800 mg/day and 2400 mg/day, showing trends in pain scores from baseline through week 7.*

FDA Label Image

Gabapentin-fig3 (Gabapentin Fig3)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' depicting two studies. Study 1 compares PBO (placebo) at 12% and GBP 3600 at 29%. Study 2 compares PBO at 14%, GBP 1800 at 32%, and GBP 2400 at 34%. Statistical significance is indicated with p-values: ** p < 0.01 and *** p < 0.001.*

FDA Label Image

Gabapentin-fig4.jpg (Gabapentin Fig4)

A chart showing percentage difference on the y-axis and daily gabapentin dose in milligrams on the x-axis. Data points correspond to three studies labeled a, b, and c, with doses at approximately 600 mg, 900 mg, 1200 mg, and 1800 mg. Each study is represented by different colored or shaded squares indicating varying percentage differences across doses.*

FDA Label Image

Label (Lbl713351199)

Gabapentin Capsules, USP 400 mg label by Bryant Ranch Prepack. The label shows the product name, strength, NDC 71335-1199-01, and quantity of 20 capsules. It includes storage instructions, a warning about dizziness, barcode, and labeler information from Burbank, CA.*

FDA Label Image

Label (Lbl7133511992)

Label for Gabapentin 400 mg capsule by Bryant Ranch Prepack. The label shows the product strength and form, compares it to Neurontin 400 mg capsule by Alkem Laboratories Limited, and indicates a 20-count package. Storage instructions specify room temperature (20°-25°C), with warnings about dizziness and keeping drugs out of children's reach. A barcode and lot number are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.